Network meta-analysis on the efficacy and safety of finerenone versus SGLT2 inhibitors on reducing new-onset of atrial fibrillation in patients with type 2 diabetes mellitus and chronic kidney disease

被引：0
作者：
Yaofu Zhang
Junheng Wang
Li Jiang
Tongxin Wang
Zhuang Li
Xiaozhe Fu
Weijun Huang
Yonghua Xiao
Shidong Wang
Jinxi Zhao
机构：
[1] Beijing University of Chinese Medicine,Dongzhimen Hospital
[2] Xiyuan Hospital,National Clinical Research Center for Chinese Medicine Cardiology
[3] China Academy of Chinese Medical Sciences,undefined
[4] Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing,undefined
[5] Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine,undefined
来源：
Diabetology & Metabolic Syndrome | / 14卷
关键词：
Atrial fibrillation; SGLT2 inhibitors; Finerenone; Type 2 diabetes mellitus; Chronic kidney disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[21]   Efficacy and safety of finerenone in chronic kidney disease associated with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials [J].
Bao, Wujisiguleng ;
Zhang, Mingzhu ;
Li, Ning ;
Yao, Zhi ;
Sun, Luying .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (12) :1877-1887
[22]   SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: a systematic review with meta-analysis of 16 randomized controlled trials [J].
Wen-jie Li ;
Xing-qing Chen ;
Ling-ling Xu ;
Yuan-qing Li ;
Bi-hui Luo .
Cardiovascular Diabetology, 19
[23]   SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: a systematic review with meta-analysis of 16 randomized controlled trials [J].
Li, Wen-jie ;
Chen, Xing-qing ;
Xu, Ling-ling ;
Li, Yuan-qing ;
Luo, Bi-hui .
CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
[24]   The Uricosuric Effect of SGLT2 Inhibitors Is Maintained in the Long Term in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus [J].
Sanchez-Briales, Paula ;
Vidas, Maria Marques ;
Lopez-Sanchez, Paula ;
Lopez-Illazquez, Maria Victoria ;
Martin-Testillano, Lucia ;
Vedat-Ali, Aylin ;
Portoles, Jose .
JOURNAL OF CLINICAL MEDICINE, 2024, 13 (05)
[25]   SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes [J].
David C. Wheeler ;
June James ;
Dipesh Patel ;
Adie Viljoen ;
Amar Ali ;
Marc Evans ;
Kevin Fernando ;
Debbie Hicks ;
Nicola Milne ;
Philip Newland-Jones ;
John Wilding .
Diabetes Therapy, 2020, 11 :2757-2774
[26]   SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes [J].
Wheeler, David C. ;
James, June ;
Patel, Dipesh ;
Viljoen, Adie ;
Ali, Amar ;
Evans, Marc ;
Fernando, Kevin ;
Hicks, Debbie ;
Milne, Nicola ;
Newland-Jones, Philip ;
Wilding, John .
DIABETES THERAPY, 2020, 11 (12) :2757-2774
[27]   Understanding the protective effects of SGLT2 inhibitors in type 2 diabetes patients with chronic kidney disease [J].
Scheen, Andre J. ;
Delanaye, Pierre .
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2022, 17 (01) :35-46
[28]   Role of Metformin in Preventing New-Onset Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus [J].
Lin, Yu-Ling ;
Lin, Sheng-Hsiang ;
Wang, Hsi-Hao ;
Hsu, Wan-Chia ;
Hung, Shih-Yuan ;
Chiou, Yuan-Yow ;
Liou, Hung-Hsiang ;
Chang, Min-Yu ;
Ho, Li-Chun ;
Wu, Ching-Fang ;
Lee, Yi-Che .
PHARMACEUTICALS, 2025, 18 (01)
[29]   Sodium glucose co-transporter 2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP-4) inhibitors and the risk of Atrial Fibrillation in patients with type 2 diabetes mellitus: a meta-analysis [J].
Liang, Xiaoyan ;
Dai, Jianghong ;
Wang, Feifei .
BMC CARDIOVASCULAR DISORDERS, 2025, 25 (01)
[30]   Finerenone Efficacy in Patients with Chronic Kidney Disease, Type 2 Diabetes, and Anemia in FIDELITY [J].
Singh, Ajay K. ;
James, Glen ;
Anker, Stefan D. ;
Pitt, Bertram ;
Rossing, Peter ;
Ruilope, Luis M. ;
Farjat, Alfredo E. ;
Farag, Youssef M. K. ;
Roberts, Luke ;
Filippatos, Gerasimos .
JACC-ADVANCES, 2025, 4 (02)
12345